CDK18 and neoplasm: Moreover, CDK18/CDK19 inhibition suppressed the tumour-promoting activities of fibroblasts [153] and decreased intra-tumoural blood supply in an AR-driven patient-derived xenograft model, the latter finding suggesting that these kinases enhance tumour angiogenesis [100].